Processed food and pharmaceutical composition having watermelon sprout-derived substances as main ingredients

US10758583B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10758583-B2
Application numberUS-201716073450-A
CountryUS
Kind codeB2
Filing dateJan 27, 2017
Priority dateJan 29, 2016
Publication dateSep 1, 2020
Grant dateSep 1, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A so-called molecular-targeted drug acting on a signal transduction pathway in a cell has been developed. However, a side effect of the molecular-targeted drug is not negligible for a patient. Thus, there has been a demand for a substance that exhibits a significant growth inhibitory effect on a cancer cell with fewer side effects as a health food and a pharmaceutical composition. It has been found that a hexane extract fraction of a watermelon sprout has an effect of specifically inhibiting the cell growth of the cancer cell and such an effect is primarily caused by phytol and lutein. A processed food and pharmaceutical composition having these substances as main components can exert an anticancer action without causing side effects.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cancer cell growth inhibitor comprising an effective amount of a hexane extract fraction of a watermelon sprout. 2. The cancer cell growth inhibitor according to claim 1 , further comprising a diluent, a lubricant, a binder, a disperant, a saturant, a colorant, a sweetener, a wetting agent, and a combination thereof. 3. The cancer cell growth inhibitor according to claim 1 , further comprising a carrier. 4. A method for producing a cancer cell growth inhibitor, comprising: washing and crushing a watermelon sprout as a pretreatment; obtaining an extract liquid by immersing the crushed watermelon sprout in a nonpolar extraction solvent; and filtering the extract liquid to produce the cancer cell growth inhibitor of claim 1 . 5. The method for producing a cancer cell growth inhibitor according to claim 4 , wherein obtaining the extract liquid includes: eluting the crushed watermelon sprout with ethanol to obtain an ethanol eluate; redissolving the ethanol eluate with distilled water to obtain a distilled water dissolved matter; and dissolving the distilled water dissolved matter with hexane. 6. A processed food comprising an effective amount of a hexane extract fraction of a watermelon sprout. 7. A method for producing a processed food, comprising: washing and crushing a watermelon sprout as a pretreatment; obtaining an extract liquid by immersing the crushed watermelon sprout in a nonpolar extraction solvent; and filtering the extract liquid to produce the processed food of claim 6 . 8. The method for producing a processed food according to claim 7 , wherein obtaining the extract liquid includes: eluting the crushed watermelon sprout with ethanol to obtain an ethanol eluate; redissolving the ethanol eluate with distilled water to obtain a distilled water dissolved matter; and dissolving the distilled water dissolved matter with hexane.

Assignees

Inventors

Classifications

  • involving mechanical treatment, e.g. chopping up, cutting or grinding · CPC title

  • Extraction with lipophilic solvents, e.g. Hexane or petrol ether · CPC title

  • A23L33/105Primary

    Plant extracts, their artificial duplicates or their derivatives · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • having two or more hydroxy groups, e.g. sorbitol · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10758583B2 cover?
A so-called molecular-targeted drug acting on a signal transduction pathway in a cell has been developed. However, a side effect of the molecular-targeted drug is not negligible for a patient. Thus, there has been a demand for a substance that exhibits a significant growth inhibitory effect on a cancer cell with fewer side effects as a health food and a pharmaceutical composition. It has been f…
Who is the assignee on this patent?
Univ Kinki, Hagihara Farm Production Inst Co Ltd
What technology area does this patent fall under?
Primary CPC classification A23L33/105. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).